Question to the Department of Health and Social Care:

To ask the Secretary of State for Health, whether the cost effectiveness modelling for the HPV vaccine and adolescent boys will take into account the costs of treating (a) genital warts, (b) anal cancer, (c) penile cancer, (d) relevant head and neck cancers, (e) vaginal cancer, (f) vulval cancer and (g) recurrent respiratory papillomatosis.

Yes. The analysis will include all costs of treatment by the National Health Service as far as practicable and/or significant.